- Filed
- Apr 28, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 27, 2026 | 134.12M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 132.38M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 45.91M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $47.33K |
| Capex | Q1 2026 · Mar 31, 2025 | $13.67K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$3.12M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$2.27M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $4.67M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $8.24M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $11.49M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $2.75M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $3.63M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $8.33M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $9.2M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $5.85M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $9.78M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $17.64M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $21.72M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.03 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.06 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.03 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.06 |
| Net Income | Q1 2026 · Mar 31, 2026 | −$4.34M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$2.85M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$4.28M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$2.42M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $552.27K |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $518.67K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $288.8K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $406.97K |
| Revenue | Q1 2026 · Mar 31, 2026 | $841.06K |
| Revenue | Q1 2026 · Mar 31, 2025 | $925.64K |